Bruce Beutler
18Patents
5h-index
12Co-inventors
63Inventor score
Filing activity: Apr 2, 1992 → Nov 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5447851A | DNA encoding a chimeric polypeptide comprising the extracellular domain of TNF receptor fused to IgG, vectors, and host cells | Chemistry; Metallurgy | 267 | Expired |
| US5616688A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5925548A | Modified receptors that continuously signal | Chemistry; Metallurgy | 8 | Expired |
| US7029861B1 | LPS-response gene compositions and methods | Physics | 6 | Expired |
| US5770402A | DNA encoding macrophage inflammatory protein-1.gamma. | Human Necessities | 6 | Expired |
| US6019969A | Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-.alpha. 1 and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6046309A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5817763A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5989836A | Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5863535A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5849873A | Macrophage-derived inflammatory mediator (MIP-1 .alpha. and MIP-1 .beta.) | Physics | 2 | Expired |
| US5741484A | Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Physics | 2 | Expired |
| US5760186A | Antibody to macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.) | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9918959B2 | TLR-independent small molecule adjuvants | Chemistry; Metallurgy | 1 | Active |
| US9649373B2 | Neoseptins: small molecule adjuvants | Chemistry; Metallurgy | 1 | Active |
| US7705199B2 | Compositions and methods for treatment of autoimmune and related diseases | Chemistry; Metallurgy | 0 | Expired |
| US11365250B2 | Compositions and methods for cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US11040959B2 | Diprovocims: a new and potent class of TLR agonists | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.